Announcements Trials
Browse Landscape

Status

Recruiting 3Active not recruiting 2

Sponsor Class

NIH 3INDUSTRY 2

Study Type

Interventional 11Observational 5Expanded_access 1

Sponsor

Cancer Type

CNS 5Sarcoma 2

Conditions

Neoplasms 271Breast Neoplasms 264Lung Neoplasms 130Prostatic Neoplasms 114Colorectal Neoplasms 108Carcinoma, Non-Small-Cell Lung 103Pancreatic Neoplasms 67Carcinoma, Hepatocellular 53Ovarian Neoplasms 51Stomach Neoplasms 49Multiple Myeloma 49Hematologic Neoplasms 49Urinary Bladder Neoplasms 47Brain Neoplasms 45Melanoma 42Leukemia, Myeloid, Acute 42Head and Neck Neoplasms 40Esophageal Neoplasms 40Colonic Neoplasms 38Disease 37Liver Neoplasms 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Rectal Neoplasms 34Lymphoma 32Neoplasm Metastasis 31Leukemia, Lymphocytic, Chronic, B-Cell 30Endometrial Neoplasms 30Recurrence 28Kidney Neoplasms 28Uterine Cervical Neoplasms 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Neurofibroma, Plexiform × 90 days × Clear all
NCT00924196 2026-06-04

Natural History Study of Patients With Neurofibromatosis Type I

National Institutes of Health Clinical Center (CC)

Active not recruiting
259 enrolled
CNSSarcoma

Neurofibroma, Neurofibromatosis 1, Neurofibroma, Plexiform, Neurofibrosarcoma, Optic Nerve Glioma

NCT06222203 2026-06-04

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

National Institutes of Health Clinical Center (CC)

Recruiting
225 enrolled
CNSSarcoma

Neurofibroma, Neurofibromatosis 1, Nerve Sheath Neoplasms, Neurofibroma, Plexiform, Neurofibrosarcoma

NCT02544022 2026-06-01

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

National Institutes of Health Clinical Center (CC)

Recruiting
476 enrolled
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

NCT06360406 2026-06-01

Real-World Treatment Study of Koselugo (Selumetinib)

AstraZeneca

Recruiting
200 enrolled
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

NCT06175637 2026-05-13

PEDIA

AstraZeneca

Active not recruiting
409 enrolled
CNS

Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡